US 11,752,353 B2
Power management for implantable medical device systems
Wade M. Demmer, Coon Rapids, MN (US); Yong K. Cho, Excelsior, MN (US); Michael F. Hess, Minneapolis, MN (US); and Todd J. Sheldon, North Oaks, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Aug. 11, 2020, as Appl. No. 16/990,188.
Application 16/990,188 is a continuation of application No. 15/783,573, filed on Oct. 13, 2017, granted, now 10,751,542.
Prior Publication US 2020/0368540 A1, Nov. 26, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/378 (2006.01); A61N 1/375 (2006.01); A61N 1/368 (2006.01); A61N 1/372 (2006.01); A61N 1/37 (2006.01); A61B 5/318 (2021.01)
CPC A61N 1/3787 (2013.01) [A61N 1/3684 (2013.01); A61N 1/3756 (2013.01); A61N 1/37288 (2013.01); A61N 1/37512 (2017.08); A61B 5/318 (2021.01); A61N 1/3708 (2013.01); A61N 1/37518 (2017.08)] 20 Claims
OG exemplary drawing
 
1. An implantable leadless pacing device which represents a first medical device, wherein the implantable leadless pacing device includes processing circuitry configured to:
cause the implantable leadless pacing device to operate together with a second medical device as a multi-chamber pacing system according to a programmed operational mode of a set of operational modes; and
communicate with the second medical device according to a communication protocol of a set of communication protocols,
wherein the communication protocol is specific to the programmed operational mode of the set of operational modes, and
wherein each operational mode of the set of operational modes indicates a set of chambers in which to deliver pacing pulses using one or both of the implantable leadless pacing device and the second medical device and indicates a set of chambers in which to sense cardiac signals using one or both of the implantable leadless pacing device and the second medical device.